FI973529L - Askomysiinejä - Google Patents

Askomysiinejä Download PDF

Info

Publication number: FI973529L
Authority: FI; Finland
Prior art keywords: ascomycins
Prior art date: 1995-04-06

Application number

FI973529A

Other languages

English (en)

Finnish (fi)

Swedish (sv)

Other versions

FI973529A7 (fi

FI973529A0 (fi

Inventor

Rene Hersperger

Reto Naef

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-04-06

Filing date

1996-04-04

Publication date

1997-11-25

1995-04-06 Priority claimed from GBGB9507128.8A external-priority patent/GB9507128D0/en

1995-12-20 Priority claimed from GBGB9526049.3A external-priority patent/GB9526049D0/en

1995-12-20 Priority claimed from GBGB9526050.1A external-priority patent/GB9526050D0/en

1996-04-04 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1997-08-27 Publication of FI973529A0 publication Critical patent/FI973529A0/fi

1997-11-25 Publication of FI973529A7 publication Critical patent/FI973529A7/fi

1997-11-25 Publication of FI973529L publication Critical patent/FI973529L/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)

FI973529A 1995-04-06 1996-04-04 Askomysiinejä FI973529L (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB9507128.8A GB9507128D0 (en)	1995-04-06	1995-04-06	Organic compounds
GBGB9526049.3A GB9526049D0 (en)	1995-12-20	1995-12-20	Organic compounds
GBGB9526050.1A GB9526050D0 (en)	1995-12-20	1995-12-20	Organic compounds
PCT/EP1996/001492 WO1996031514A1 (en)	1995-04-06	1996-04-04	Ascomycins

Publications (3)

Publication Number	Publication Date
FI973529A0 FI973529A0 (fi)	1997-08-27
FI973529A7 FI973529A7 (fi)	1997-11-25
FI973529L true FI973529L (fi)	1997-11-25

Family

ID=27267660

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI973529A FI973529L (fi)	1995-04-06	1996-04-04	Askomysiinejä

Country Status (21)

Country	Link
US (1)	US5925649A (no)
EP (1)	EP0819130A1 (no)
JP (1)	JP2000505044A (no)
KR (1)	KR19980703583A (no)
CN (1)	CN1088068C (no)
AR (1)	AR004480A1 (no)
AU (1)	AU703523B2 (no)
BR (1)	BR9604808A (no)
CA (1)	CA2216562A1 (no)
CO (1)	CO4750668A1 (no)
CZ (1)	CZ312397A3 (no)
FI (1)	FI973529L (no)
HU (1)	HUP9801993A3 (no)
IL (1)	IL117815A (no)
MX (1)	MX9707636A (no)
NO (1)	NO309273B1 (no)
NZ (1)	NZ307170A (no)
PL (1)	PL322553A1 (no)
SK (1)	SK133997A3 (no)
TR (1)	TR199700999T1 (no)
WO (1)	WO1996031514A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR200002771T2 (tr)	1998-03-26	2001-02-21	Fujisawa Pharmaceutical Co.,Ltd.	Devamlı salımı olan preparatlar
JP3732525B2 (ja) *	1998-04-27	2006-01-05	アステラス製薬株式会社	医薬組成物
GB9826656D0 (en)	1998-12-03	1999-01-27	Novartis Ag	Organic compounds
US6121257A (en) *	1999-03-31	2000-09-19	Abbott Laboratories	Sulfamate containing macrocyclic immunomodulators
MXPA01010988A (es) *	1999-04-30	2004-04-21	Sucampo Ag	Uso de un compuesto macrolido para el tratamiento del ojo seco.
US7063857B1 (en)	1999-04-30	2006-06-20	Sucampo Ag	Use of macrolide compounds for the treatment of dry eye
EP1210121A2 (en)	1999-08-24	2002-06-05	Cellgate Inc.	Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
AR033151A1 (es) *	2001-04-12	2003-12-03	Sucampo Pharmaceuticals Inc	Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares
WO2002089796A2 (en) *	2001-05-09	2002-11-14	Novartis Ag	Methods for selective immunomodulation using pimecrolimus
TWI324925B (en) *	2001-08-23	2010-05-21	Novartis Ag	Ophthalmic composition
PL376169A1 (en) *	2002-11-15	2005-12-27	Novartis Ag	Drug delivery system
US20060115522A1 (en) *	2003-02-17	2006-06-01	Cipla Ltd	Pharmaceutical composition
TWI324604B (en)	2003-06-18	2010-05-11	Novartis Ag	New use of staurosporine derivatives
US7780973B2 (en) *	2003-12-15	2010-08-24	Ethicon Endo-Surgery, Inc.	Method and device for minimally invasive implantation of biomaterial
US20050142161A1 (en) *	2003-12-30	2005-06-30	Freeman Lynetta J.	Collagen matrix for soft tissue augmentation
CA2552305A1 (en) *	2003-12-30	2005-07-14	Astellas Pharma Inc.	Use of macrolides for treating or preventing airflow obstruction
WO2006082588A2 (en) *	2005-02-07	2006-08-10	Pharmalight Inc.	Method and device for ophthalmic administration of active pharmaceutical ingredients
CN107106588B (zh)	2014-10-28	2020-08-11	山口晃史	用于改善妊娠状态的药剂及其使用
CN112533599A (zh)	2018-08-10	2021-03-19	山口晃史	与母体和胎儿的关系中的体液免疫相关的疾病的治疗药
WO2020129348A1 (ja)	2018-12-18	2020-06-25	晃史山口	不妊・不育症または妊娠状態を改善するための薬剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3244592A (en) *	1962-06-09	1966-04-05	Arai Tadashi	Ascomycin and process for its production
US4894366A (en) *	1984-12-03	1990-01-16	Fujisawa Pharmaceutical Company, Ltd.	Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
JPS6317884A (ja) *	1986-05-30	1988-01-25	Fujisawa Pharmaceut Co Ltd	トリシクロ化合物
JPH01125394A (ja) *	1987-11-10	1989-05-17	Mect Corp	シアロシルグリセロリピッド類及びその製造方法
ATE120466T1 (de) *	1987-12-09	1995-04-15	Fisons Plc	Makrozyklische verbindungen.
EP0487593A1 (en) *	1989-08-18	1992-06-03	FISONS plc	Macrocyclic compounds
KR0159766B1 (ko) *	1989-10-16	1998-12-01	후지사와 토모키치로	양모제 조성물
DK0427680T3 (da) *	1989-11-09	1995-12-18	Sandoz Ltd	Heteroatom-holdige cykliske forbindelser
WO1991013899A1 (en) *	1990-03-12	1991-09-19	Fujisawa Pharmaceutical Co., Ltd.	Tricyclo compounds
WO1991019495A1 (en) *	1990-06-11	1991-12-26	Fujisawa Pharmaceutical Co., Ltd.	Use of a macrolide compound such as fk 506 for manufacturing a medicament for treating idiopathic thrombocytopenic purpura and basedow's disease
MY110418A (en) *	1990-07-02	1998-05-30	Novartis Ag	Heteroatoms-containing tricyclic compounds.
EP0474126B1 (en) *	1990-09-04	1997-03-19	Fujisawa Pharmaceutical Co., Ltd.	Ointments containing tricyclic compound
IE65341B1 (en) *	1990-11-08	1995-10-18	Fujisawa Pharmaceutical Co	Suspensions containing tricyclic compounds
US5208241A (en) *	1991-09-09	1993-05-04	Merck & Co., Inc.	N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
US5252732A (en) *	1991-09-09	1993-10-12	Merck & Co., Inc.	D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity
US5247076A (en) *	1991-09-09	1993-09-21	Merck & Co., Inc.	Imidazolidyl macrolides having immunosuppressive activity
US5457194A (en) *	1993-03-17	1995-10-10	Abbott Laboratories	Substituted aliphatic amine-containing macrocyclic immunomodulators
DE69525957T2 (de) *	1994-10-26	2002-11-14	Novartis Ag	Verwendung eines ungesättigten Fettalkohols

1996
- 1996-04-02 AR ARP960102027A patent/AR004480A1/es unknown
- 1996-04-03 IL IL11781596A patent/IL117815A/xx not_active IP Right Cessation
- 1996-04-03 CO CO96016454A patent/CO4750668A1/es unknown
- 1996-04-04 WO PCT/EP1996/001492 patent/WO1996031514A1/en not_active Ceased
- 1996-04-04 EP EP96913486A patent/EP0819130A1/en not_active Withdrawn
- 1996-04-04 JP JP8529996A patent/JP2000505044A/ja active Pending
- 1996-04-04 BR BR9604808A patent/BR9604808A/pt active Search and Examination
- 1996-04-04 KR KR1019970706988A patent/KR19980703583A/ko not_active Ceased
- 1996-04-04 PL PL96322553A patent/PL322553A1/xx unknown
- 1996-04-04 CN CN96193091A patent/CN1088068C/zh not_active Expired - Fee Related
- 1996-04-04 SK SK1339-97A patent/SK133997A3/sk unknown
- 1996-04-04 AU AU56453/96A patent/AU703523B2/en not_active Ceased
- 1996-04-04 US US08/930,730 patent/US5925649A/en not_active Expired - Fee Related
- 1996-04-04 NZ NZ307170A patent/NZ307170A/xx unknown
- 1996-04-04 CZ CZ973123A patent/CZ312397A3/cs unknown
- 1996-04-04 HU HU9801993A patent/HUP9801993A3/hu unknown
- 1996-04-04 CA CA002216562A patent/CA2216562A1/en not_active Abandoned
- 1996-04-04 TR TR97/00999T patent/TR199700999T1/xx unknown
- 1996-04-04 FI FI973529A patent/FI973529L/fi unknown
1997
- 1997-10-01 NO NO974536A patent/NO309273B1/no not_active IP Right Cessation
- 1997-10-03 MX MX9707636A patent/MX9707636A/es not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR19980703583A (ko)	1998-11-05
US5925649A (en)	1999-07-20
HUP9801993A3 (en)	2000-04-28
EP0819130A1 (en)	1998-01-21
FI973529A7 (fi)	1997-11-25
JP2000505044A (ja)	2000-04-25
BR9604808A (pt)	1998-06-09
NZ307170A (en)	1999-03-29
NO974536D0 (no)	1997-10-01
IL117815A0 (en)	1996-08-04
IL117815A (en)	2000-07-16
AU703523B2 (en)	1999-03-25
PL322553A1 (en)	1998-02-02
TR199700999T1 (xx)	1998-01-21
NO309273B1 (no)	2001-01-08
AR004480A1 (es)	1998-12-16
WO1996031514A1 (en)	1996-10-10
CZ312397A3 (cs)	1998-01-14
CA2216562A1 (en)	1996-10-10
CN1180359A (zh)	1998-04-29
CO4750668A1 (es)	1999-03-31
FI973529A0 (fi)	1997-08-27
MX9707636A (es)	1998-06-30
CN1088068C (zh)	2002-07-24
NO974536L (no)	1997-10-01
AU5645396A (en)	1996-10-23
HUP9801993A2 (hu)	1998-12-28
SK133997A3 (en)	1998-05-06

Publication	Publication Date	Title
FI973529A7 (fi)	1997-11-25	Askomysiinejä
ATE198470T1 (de)	2001-01-15	Alkenyl-benzoylguanidine
ATE240972T1 (de)	2003-06-15	Cyclopeptolide
BR9503866A (pt)	1997-10-14	Autolabor
BR9501643A (pt)	1997-09-16	Helistato
SE9501165D0 (sv)	1995-03-31	Hållaranordning
BR7501426U (pt)	1997-11-18	Búlica
BR7501299U (pt)	1997-09-16	Geladeira-prática
BR7501303U (pt)	1997-09-16	Dupla-embalagem
BR7501858U (pt)	1997-08-19	Tellelight
BR9505068A (pt)	1997-10-14	Stetro
BR7501376U (pt)	1997-09-16	Massarreal
BR7501836U (pt)	1997-08-19	Protecheque
BR9503701A (pt)	1997-09-16	Ciclo-nautica
BR9502958A (pt)	1997-09-23	Artermogeo
BR7501828U (pt)	1997-08-19	Multicopo
BR7501485U (pt)	1997-11-18	Fibropiso
BR7501467U (pt)	1997-11-18	Vassourágua
BR9502885A (pt)	1997-09-23	Casarreal
BR9502823A (pt)	1997-09-23	Proteserra
BR7501437U (pt)	1997-11-18	Leiteira
BR9502272A (pt)	1997-08-05	Livro-cartão
FIU950509U0 (fi)	1995-12-01	Skjutregel
BR7500192U (pt)	1995-06-06	Parasitofiltro
FI950644A0 (fi)	1995-02-14	Skaeranordning foer energived